Glyfoline induces mitotic catastrophe and apoptosis in cancer cells

Yi-Chen Wu1, Wen-Yen Yen, Hsiao-Yung Ho

  • 1Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan, Republic of China.

Insights

Glyfoline causes cancer cell death by inducing mitotic catastrophe, a process involving abnormal cell division. This occurs independently of the spindle checkpoint, leading to apoptosis.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Pharmacology

Background:

  • Glyfoline demonstrates in vitro cytotoxic and in vivo antitumor activity against solid tumors.
  • The precise molecular mechanisms underlying glyfoline's therapeutic effects remain largely unknown.

Purpose of the Study:

  • To elucidate the mechanism of action of glyfoline in cancer cells.
  • To investigate glyfoline's effects on cell cycle progression, mitosis, and cell death pathways.

Main Methods:

  • Human cancer cell lines were treated with glyfoline.
  • Cell cycle progression, mitotic spindle formation, and apoptosis markers were analyzed.
  • The role of Eg5 kinesin and spindle checkpoint proteins (BUBR1, MAD2) was assessed using inhibitors and RNA interference.

Main Results:

  • Glyfoline inhibited cell growth and induced mitotic arrest with spindle abnormalities, indicative of mitotic catastrophe.
  • Glyfoline enhanced microtubule aster formation and increased spindle resistance to disassembly.
  • Eg5 inhibition reduced glyfoline-induced multipolarity, while spindle checkpoint silencing did not affect mitotic catastrophe or apoptosis.
  • Glyfoline treatment led to poly(ADP-ribose) polymerase degradation and increased annexin V-positive cells, indicating apoptosis.

Conclusions:

  • Glyfoline induces mitotic catastrophe and subsequent apoptosis in cancer cells.
  • The mechanism involves enhanced microtubule aster formation and is independent of spindle checkpoint function.
  • Glyfoline represents a potential therapeutic agent targeting mitotic processes in cancer.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...